xMAP technology: A benchmark for serological testing
11 August 2020
In this white paper, Luminex outlines the applications and benefits of its xMAP technology for serological analysis. Multiplex serological testing can be particularly useful in a pandemic, as it can simultaneously analyze large numbers of antigens for large-scale screening and has the potential to replace traditional ELISA assays. Here, it is demonstrated that xMAP technology has become an established benchmark for running these multiplex serology tests.